DAUNOBLASTINA

This brand name is authorized in Brazil, Estonia, Spain, Hong Kong, Singapore

Active ingredients

The drug DAUNOBLASTINA contains one active pharmaceutical ingredient (API):

1 Daunorubicin
UNII UD984I04LZ - DAUNORUBICIN HYDROCHLORIDE

Daunorubicin is an anthracycline glycoside antibiotic and is a potent antileukaemic agent. It also has immunosuppressant effects. Daunorubicin may involve binding to DNA by intercalation between base pairs and inhibition of DNA and RNA synthesis by template disordering and steric obstruction.

Read about Daunorubicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01DB02 Daunorubicin L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522718030074317
Country: EE Ravimiamet Identifier(s): 1011159
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 46427
Country: HK Department of Health Drug Office Identifier(s): 06215
Country: SG Health Sciences Authority Identifier(s): 00774P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.